Finally, these results revealed that concurrent enrichment of PD-L1 and glycolysis associate with worse patient survival than just glycolysis enrichment without PD-L1, thereby indicating possible synergy in functional aspects of immune suppression and metabolic plasticity in cancer progression. Here, CD274 is linked to cancer.